Evonik acclaims FTC's open competition for implant-grade PEEK for medical use in US market

摘要

EVONIK Corporation commends the Federal Trade Commission's (FTC) recent vote to open competition in the U.S. polyetheretherketone (PEEK) market for implant-grade medical applications and welcomes the opportunity to compete fairly in the U.S. implant-grade polymers market. The FTC issued its decision and proposed consent order for public comment, which sets forth procedures for existing contracts of PEEK-customers to be modified to eliminate the requirement that the customer purchases PEEK for existing products exclusively from the market leader.